# Richard K. Russell

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/richard-k-russell/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,873 |
| Field | Inflammatory Bowel Disease |
| h-index | 68 |
| i10-index | 169 |
| OpenAlex ID | https://openalex.org/A5060061551 |
| ORCID iD | https://orcid.org/0000-0001-7398-4926 |
| Works | 378 |

## Researcher papers

Showing 12 of 14.

- [Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease](https://scholariq.org/papers/host-microbe-interactions-have-shaped-the-genetic-architecture-of-inflammatory/)
- [Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci](https://scholariq.org/papers/genome-wide-meta-analysis-increases-to-71-the-number-of-confirmed-crohn-s/)
- [Pediatric modification of the Montreal classification for inflammatory bowel disease](https://scholariq.org/papers/pediatric-modification-of-the-montreal-classification-for-inflammatory-bowel/)
- [ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents](https://scholariq.org/papers/espghan-revised-porto-criteria-for-the-diagnosis-of-inflammatory-bowel-disease/)
- [Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47](https://scholariq.org/papers/meta-analysis-identifies-29-additional-ulcerative-colitis-risk-loci-increasing/)
- [Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease](https://scholariq.org/papers/consensus-guidelines-of-ecco-espghan-on-the-medical-management-of-pediatric/)
- [The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update](https://scholariq.org/papers/the-medical-management-of-paediatric-crohn-s-disease-an-ecco-espghan-guideline/)
- [Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study](https://scholariq.org/papers/predictors-of-anti-tnf-treatment-failure-in-anti-tnf-naive-patients-with-active/)
- [Common variants at five new loci associated with early-onset inflammatory bowel disease](https://scholariq.org/papers/common-variants-at-five-new-loci-associated-with-early-onset-inflammatory-bowel/)
- [Management of Paediatric Ulcerative Colitis, Part 1](https://scholariq.org/papers/management-of-paediatric-ulcerative-colitis-part-1/)
- [HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease](https://scholariq.org/papers/hla-dqa1-05-carriage-associated-with-development-of-anti-drug-antibodies-to/)
- [ECCO-ESCP Consensus on Surgery for Crohn’s Disease](https://scholariq.org/papers/ecco-escp-consensus-on-surgery-for-crohn-s-disease/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Gut microbiota and health](https://scholariq.org/topics/gut-microbiota-and-health/)
- [Celiac Disease Research and Management](https://scholariq.org/topics/celiac-disease-research-and-management/)
- [Adolescent and Pediatric Healthcare](https://scholariq.org/topics/adolescent-and-pediatric-healthcare/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.